Latest News about ABT
Recent news which mentions ABT
10 S&P 500 Stocks to Buy After Winning in Q3
November 05, 2021
From InvestorPlace
7 Dividend Aristocrat Stocks That Should Grace Your Portfolio
November 03, 2021
From InvestorPlace
2 Growth Stocks That Could Deliver 1,000% Returns
October 31, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2021
October 27, 2021
From Benzinga
AbbVie Takes Another Step Toward Its Post-Humira Future
October 27, 2021
From Motley Fool
Got $5,000? These 2 Unstoppable Stocks Are No-Brainer Buys
October 26, 2021
From Motley Fool
Kimberly-Clark's Earnings Remind Investors that Inflation and Supply Chain Issues are Still a Major Theme
October 25, 2021
From Benzinga
What Could These Clinical Results Mean for AbbVie's Shareholders?
October 25, 2021
From Motley Fool
A-List Executive Team, Big-Name Backers Fail to Lift Abbisko IPO
October 22, 2021
From Benzinga
Why Senseonics Holdings Stock Popped This Week
October 22, 2021
From Motley Fool
10 Biggest Price Target Changes For Thursday
October 21, 2021
From Benzinga
3 Things Investors Should Love About Abbott's Q3 Results
October 21, 2021
Tickers
ABT
From Motley Fool
Abbott Laboratories (ABT) Q3 2021 Earnings Call Transcript
October 20, 2021
Tickers
ABT
From Motley Fool
Abbot Labs and Biogen Outshine Novavax in the Health Care Sector
October 20, 2021
From Benzinga
A Crowded Earnings Calendar Ahead
October 20, 2021
From Benzinga
Abbott's Q3 Profit Jumps 70% On Robust COVID-19 Test Sales
October 20, 2021
Tickers
ABT
From Benzinga
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
October 20, 2021
From Benzinga
From Benzinga
From MarketWatch
5 Stocks To Watch For October 20, 2021
October 20, 2021
From Benzinga
Earnings Scheduled For October 20, 2021
October 20, 2021
From Benzinga
Neovasc Receives FDA Approval for COSIRA-II Clinical Trial
October 19, 2021
From Benzinga
Jim Cramer Suggests How To Play Earnings The Week Of October 18
October 18, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
From Benzinga
3 Solid Growth Stocks Perfect for Retirees
October 17, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.